Abstract
e12037 Background: In-spite of increased chemo-sensitivity, except for TNBC patients (Pts) with pCR after neo-adjuvant chemotherapy who do extremely well, most Pts with residual disease eventually ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have